Intrinsic Value of S&P & Nasdaq Contact Us

Penumbra, Inc. PEN NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
3/7 Pass
SharesGrow Intrinsic Value
$304.88
-8.2%
Analyst Price Target
$371.92
+12%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Penumbra, Inc. (PEN) trades at a trailing P/E of 72.7, forward P/E of 66.3. Trailing earnings yield is 1.38%, forward earnings yield 1.51%. PEG 0.06 (Peter Lynch undervalued ≤1.0). Graham Number is $60.96.

Criteria proven by this page:

  • VALUE (32/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 72.7).
  • Forward P/E 66.3 (down from trailing 72.7) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.38% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.51% as earnings recover.
  • Analyst consensus target $371.92 (+12% upside) — modest upside expected.

Overall SharesGrow Score: 67/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
80/100
→ Income
GROWTH
90/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — PEN

Valuation Multiples
P/E (TTM)72.7
Forward P/E66.3
PEG Ratio0.06
Forward PEG6.14
P/B Ratio9.05
P/S Ratio9.22
EV/EBITDA58.0
Per Share Data
EPS (TTM)$4.53
Forward EPS (Est.)$5.01
Book Value / Share$36.43
Revenue / Share$35.82
FCF / Share$4.46
Yields & Fair Value
Earnings Yield1.38%
Forward Earnings Yield1.51%
Dividend Yield0.00%
Graham Number$60.96
SharesGrow IV$304.88 (-8.2%)
Analyst Target$371.92 (+12%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 131.2 0.30 7.29 7.38 -
2017 666.4 -9.33 7.75 9.30 -
2018 668.1 23.38 10.44 9.91 -
2019 117.8 0.18 11.75 10.43 -
2020 -398.6 2.87 9.76 11.17 -
2021 1,999.1 -15.88 11.07 14.13 -
2022 -4,204.9 30.52 8.43 9.94 -
2023 106.2 -0.02 8.19 9.13 -
2024 654.8 -7.72 7.97 7.68 -
2025 68.1 0.06 8.48 8.62 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.44 $263.32M $14.81M 5.6%
2017 $0.13 $333.76M $4.66M 1.4%
2018 $0.18 $444.94M $6.6M 1.5%
2019 $1.34 $547.41M $48.46M 8.9%
2020 $-0.54 $560.41M $-19.26M -3.4%
2021 $0.07 $747.59M $2.62M 0.4%
2022 $-0.05 $847.13M $-2M -0.2%
2023 $2.32 $1.06B $90.95M 8.6%
2024 $0.36 $1.19B $14.01M 1.2%
2025 $4.52 $1.4B $177.69M 12.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.01 $4.68 – $5.37 $1.59B $1.55B – $1.63B 9
2027 $6.33 $5.49 – $6.93 $1.81B $1.74B – $1.85B 10
2028 $7.60 $7.03 – $8.91 $2.04B $2.02B – $2.06B 4
2029 $9.25 $8.88 – $9.93 $2.26B $2.2B – $2.39B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message